(I'm looking for a place in this one... Arotech is significantly undervalued despite being a small and growing firm with promising future bullish catalysts. ARTX offers solid fundamentals, highlighted by the Piotroski F-Score, that are rarely seen with companies comparable to it. Taking all into consideration we believe that ARTX is currently undervalued by 50% and are setting a short-term price target of $7.85.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.